Armand Glassman to Karyotyping
This is a "connection" page, showing publications Armand Glassman has written about Karyotyping.
Connection Strength
0.848
-
The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia. Cancer Genet Cytogenet. 2005 Apr 01; 158(1):88-91.
Score: 0.066
-
Determination of secondary chromosomal aberrations of chronic myelocytic leukemia. Cancer Genet Cytogenet. 2004 Aug; 153(1):53-6.
Score: 0.063
-
Cytogenetic findings in blastoid mantle cell lymphoma. Hum Pathol. 2003 Oct; 34(10):1022-9.
Score: 0.059
-
Detection of a novel reciprocal t(16;22)(q11.2;q12) in a Ewing sarcoma. Cancer Genet Cytogenet. 2003 Jan 01; 140(1):55-7.
Score: 0.056
-
Translocation (11;16)(q23;p13) acute myelogenous leukemia and myelodysplastic syndrome. Ann Clin Lab Sci. 2003; 33(3):285-8.
Score: 0.056
-
Spectral karyotyping study of chromosome abnormalities in human leukemia. Cancer Genet Cytogenet. 2001 Jun; 127(2):143-7.
Score: 0.050
-
A unique, complex variant philadelphia chromosome translocation in a patient with typical chronic myelogenous leukemia. Arch Pathol Lab Med. 2001 Mar; 125(3):437-9.
Score: 0.049
-
Detection of trisomy 8 in philadelphia chromosome-positive CML patients using conventional cytogenetic and interphase fluorescence in situ hybridization techniques and its relation to c-myc involvement. Ann Clin Lab Sci. 2001 Jan; 31(1):68-74.
Score: 0.049
-
Cytogenetics as an aid in the diagnosis of lymphomas. Ann Clin Lab Sci. 2000 Jan; 30(1):72-4.
Score: 0.046
-
Cytogenetics, in situ hybridization and molecular approaches in the diagnosis of cancer. Ann Clin Lab Sci. 1998 Nov-Dec; 28(6):324-30.
Score: 0.042
-
A simple efficient method of sequential G-banding and fluorescence in situ hybridization. Cancer Genet Cytogenet. 1998 May; 103(1):62-4.
Score: 0.041
-
Chromosome 6 abnormalities associated with prolymphocytic acceleration in chronic lymphocytic leukemia. Ann Clin Lab Sci. 1998 Jan-Feb; 28(1):24-9.
Score: 0.040
-
Cytogenetics. An evolving role in the diagnosis and treatment of cancer. Clin Lab Med. 1997 Mar; 17(1):21-37.
Score: 0.037
-
The relationship between age and karyotypic abnormalities in myelodysplastic syndromes. Cancer Genet Cytogenet. 1996 May; 88(1):80-2.
Score: 0.035
-
Breast cancer cytogenetics: a review and proposal for clinical application. Ann Clin Lab Sci. 1996 May-Jun; 26(3):208-14.
Score: 0.035
-
Translocation (X;10)(p10;p10): A rare but nonrandom chromosomal abnormality in acute leukemia of myeloid differentiation. Cancer Genet Cytogenet. 1996 Feb; 86(2):153-5.
Score: 0.035
-
der(1;15)(q10;10): a nonrandom chromosomal abnormality of myeloid neoplasia. Cancer Genet Cytogenet. 1995 Sep; 83(2):144-7.
Score: 0.034
-
Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenstr?m macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course. Am J Clin Pathol. 2001 Oct; 116(4):543-9.
Score: 0.013
-
11q23 abnormalities in patients with acute myelogenous leukemia and myelodysplastic syndrome as detected by molecular and cytogenetic analyses. Am J Clin Pathol. 2000 Nov; 114(5):793-7.
Score: 0.012
-
Detection of chromosome 11q13 breakpoints by interphase fluorescence in situ hybridization. A useful ancillary method for the diagnosis of mantle cell lymphoma. Am J Clin Pathol. 2000 Aug; 114(2):248-57.
Score: 0.012
-
Prognostic value of cytogenetics in multiple myeloma. Br J Haematol. 1998 Apr; 101(1):189-94.
Score: 0.010
-
Usefulness of detection of minimal residual disease by 'hypermetaphase' fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemia. Bone Marrow Transplant. 1997 Mar; 19(6):565-70.
Score: 0.009